Announced

Completed

OrbiMed led a $32m Series C round in Pee Safe.

Synopsis

OrbiMed, a private equity firm, led a $32m Series C round in Pee Safe, a women’s hygiene and wellness brand. “Pee Safe was founded to address a deeply underserved women’s health category and challenge long-standing taboos. Partnering with OrbiMed, who share our conviction in the consumer healthcare opportunity, marks an important step in Pee Safe’s next phase,” Vikas Bagaria, Pee Safe Founder and CEO.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2026 Datasite

MergerLinks - OrbiMed led a $32m Series C round in Pee Safe.